Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 232-237

  Amdursky, Nadav ^a,b   Gazit, Ehud ^a   Rosenman, Gil ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Amyloid proteins; Self assembly; Spectroscopy

Indexed keywords

AMYLOID PROTEIN; CRYSTALLIN; EPIGALLOCATECHIN GALLATE; INSULIN; MONOMER; NANOMATERIAL;

ARTICLE; CELL NUCLEUS; ELECTRON; FIBER; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SECONDARY STRUCTURE; SPECTROSCOPY;

AMYLOID; CATECHIN; CIRCULAR DICHROISM; CRYSTALLIZATION; HUMANS; INSULIN; MICROSCOPY, ATOMIC FORCE; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE;

EID: 84857994204     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.153     Document Type: Article

References (40)

1. Bhak G., Choe Y.J., Paik S.R. Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep. 2009, 42:541-551.
2. Kirkitadze M.D., Condron M.M., Teplow D.B. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 2001, 312:1103-1119.
3. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl. Acad. Sci. USA 1997, 94:7942-7947.
4. Mauro M., Craparo E.F., Podesta A., Bulone D., Carrotta R., Martorana V., Tiana G., San Biagio P.L. Kinetics of different processes in human insulin amyloid formation. J. Mol. Biol. 2007, 366:258-274.
5. Naiki H., Gejyo F. Kinetic analysis of amyloid fibril formation. Methods Enzymol. 1999, 309:305-318.
6. Rochet J.C., Lansbury P.T. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 2000, 10:60-68.
7. Necula M., Kayed R., Milton S., Glabe C.G. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 2007, 282:10311-10324.
8. Yang D.S., Yip C.M., Huang T.H.J., Chakrabartty A., Fraser P.E. Manipulating the amyloid-beta aggregation pathway with chemical chaperones. J. Biol. Chem. 1999, 274:32970-32974.
9. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., Teplow D.B. Amyloid beta-protein (A beta) assembly: a beta 40 and a beta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 2003, 100:330-335.
10. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C.F. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997, 273:729-739.
11. Reches M., Gazit E. Casting metal nanowires within discrete self-assembled peptide nanotubes. Science 2003, 300:625-627.
12. Amdursky N., Gazit E., Rosenman G. Quantum confinement in self-assembled bio-inspired peptide hydrogels. Adv. Mater. 2010, 22:2311-2315.
13. Amdursky N., Molotskii M., Gazit E., Rosenman G. Self-assembled bioinspired quantum dots: optical properties. Appl. Phys. Lett. 2009, 94:261907.
14. Amdursky N., Molotskii M., Gazit E., Rosenman G. Elementary building blocks of self-assembled peptide nanotubes. J. Am. Chem. Soc. 2010, 132:15632-15636.
15. Nielsen L., Frokjaer S., Brange J., Uversky V.N., Fink A.L. Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 2001, 40:8397-8409.
16. Teale F.W.J. Ultraviolet fluorescence of proteins in neutral solution. Biochem. J. 1960, 76:381-388.
17. Nelson R.J. In Excitons 1982, North-Holland, Amsterdam.
18. Schubert E.F., Gobel E.O., Horikoshi Y., Ploog K., Queisser H.J. Alloy broadening in photoluminescence spectra of alxga1-xas. Phys. Rev. B 1984, 30:813-820.
19. Eberhardt J., Metzner H., Hahn T., Reislohner U., Cieslak J., Grossner U., Goldhahn R., Hudert F., Gobsch G., Witthuhn W. Optical properties of epitaxial CuGaS2 layers on Si(111). J. Phys. Chem. Solids 2003, 64:1781-1785.
20. Svelto O. Principles of Lasers 1998, Pleneum Press, New York.
21. Muth J.F., Lee J.H., Shmagin I.K., Kolbas R.M., Casey H.C., Keller B.P., Mishra U.K., DenBaars S.P. Absorption coefficient, energy gap, exciton binding energy, and recombination lifetime of GaN obtained from transmission measurements. Appl. Phys. Lett. 1997, 71:2572-2574.
22. Andrade M.A., Chacon P., Merelo J.J., Moran F. Evaluation of secondary structure of proteins from Uv circular-dichroism spectra using an unsupervised learning neural-network. Protein Eng. 1993, 6:383-390.
23. Ganim Z., Jones K.C., Tokmakoff A. Insulin dimer dissociation and unfolding revealed by amide I two-dimensional infrared spectroscopy. Phys. Chem. Chem. Phys. 2010, 12:3579-3588.
24. Kim T., Rhee A., Yip C.M. Force-induced insulin dimer dissociation: a molecular dynamics study. J. Am. Chem. Soc. 2006, 128:5330-5331.
25. Chang X.Q., Jorgensen A.M.M., Bardrum P., Led J.J. Solution structures of the R-6 human insulin hexamer. Biochemistry 1997, 36:9409-9422.
26. Fabris D., Fenselau C. Characterization of allosteric insulin hexamers by electrospray ionization mass spectrometry. Anal. Chem. 1999, 71:384-387.
27. Ahmad A., Uversky V.N., Hong D., Fink A.L. Early events in the fibrillation of monomeric insulin. J. Biol. Chem. 2005, 280:42669-42675.
28. Liu R., He M.X., Su R.X., Yu Y.J., Qi W., He Z.M. Insulin amyloid fibrillation studied by terahertz spectroscopy and other biophysical methods. Biochem. Biophys. Res. Commun. 2010, 391:862-867.
29. Pease L.F., Sorci M., Guha S., Tsai D.-H., Zachariah M.R., Tarlov M.J., Belfort G. Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis. Biophys. J. 2010, 99:3979-3985.
30. Vestergaard B., Groenning M., Roessle M., Kastrup J.S., van de Weert M., Flink J.M., Frokjaer S., Gajhede M., Svergun D.I. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 2007, 5:1089-1097.
31. Lee C.C., Nayak A., Sethuraman A., Belfort G., McRae G.J. A three-stage kinetic model of amyloid fibrillation. Biophys. J. 2007, 92:3448-3458.
32. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
33. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V.N., Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001, 40:6036-6046.
34. Porat Y., Abramowitz A., Gazit E. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67:27-37.
35. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. Faseb. J. 2002, 16:77-83.
36. Cao A.E., Hu D.Y., Lai L.H. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 2004, 13:319-324.
37. Sasahara K., Yagi H., Naiki H., Goto Y. Heat-induced conversion of beta(2)-Microglobulin and hen egg-white lysozyme into amyloid fibrils. J. Mol. Biol. 2007, 372:981-991.
38. Leckstrom A., Lundquist I., Ma Z., Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 1999, 18:266-273.
39. Bates K.A., Verdile G., Li Q.X., Ames D., Hudson P., Masters C.L., Martins R.N. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol. Psy. 2009, 14:469-486.
40. Fjorback A.W., Varming K., Jensen P.H. Determination of alpha-synuclein concentration in human plasma using ELISA. Scand. J. Clin. Lab. Invest. 2007, 67:431-435.